Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02917720
Title 2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European LeukemiaNet
Indications

chronic myeloid leukemia

Therapies

Nilotinib

Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.